Claims
- 1. A heterocyclic compound of the general formula: ##STR24## wherein ring A and ring B each mean a benzene ring which is unsubstituted or substituted by 1 to 4 substituents selected from a group consisting of a halogen, C.sub.1-6 alkyl optionally halogenated, C.sub.1-6 alkoxy optionally halogenated, C.sub.1-6 alkylthio optionally halogenated, C.sub.1-3 acyloxy, di-C.sub.1-6 alkylamino and hydroxy; X means a group of the formula: ##STR25## wherein R.sup.2 is hydrogen, an alkyl or an alkoxy; m is 0 or 1, or the formula: ##STR26## wherein R.sup.3 is hydrogen or an alkyl; Y means a bond, --NH--, and C.sub.1 or 2 alkylene group or --CH.dbd.CH--; R.sup.1 is a C.sub.1-8 alkyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkyl-C.sub.1-4 alkyl, C.sub.6-10 aryl or C.sub.7-16 aralkyl group optionally substituted by 1 to 5 substituents selected from a group consisting of a halogen, C.sub.1-6 alkyl optionally halogenated, C.sub.1-6 alkoxy optionally halogenated, C.sub.1-6 alkylthio which may be halogenated, C.sub.1-3 acyloxy, di-C.sub.1-6 alkylamino and hydroxy; and n means a whole number of 3 through 6, or a pharmaceutically acceptable salt thereof.
- 2. A compound as claimed in claim 1, wherein the alkyl is a C.sub.1-6 alkyl.
- 3. A compound as claimed in claim 1, wherein the alkoxy is a C.sub.1-6 alkoxy.
- 4. A compound as claimed in claim 1, wherein the ring A is a benzene ring substituted by 1 to 3 substituents selected from a group consisting of halogen, C.sub.1-6 alkyl and hydroxy; the ring B is a benzene ring; X is a group of the formula: ##STR27## wherein R.sup.2 is hydrogen or a C.sub.1-6 alkoxy, the formula: ##STR28## wherein R.sup.3 is a C.sub.1-6 alkyl; Y is --NH--, an C.sub.1 or 2 alkylene group or --CH=CH--; R.sup.1 is a phenyl group substituted by 1 to 3 substituents selected from a group consisting of a halogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, C.sub.1-6 acyloxy,. di-C.sub.1-6 alkylamino and hydroxy; and n is 3.
- 5. A compound as claimed in claim 1, wherein the ring A is a benzene ring substituted by halogen or C.sub.1-6 alkyl; the ring B is a benzene ring; X is a group of the formula: --N=CH--; Y is --NH--; R.sup.1 is ##STR29## and n is 3
- 6. A compound as claimed in claim 5, which is N-[4-(2-chlorophenyl)-7,8-dihydro-6H-cyclopenta[g]quinolin -3-yl]-N'-(2,4-difluorophenyl)urea.
- 7. An acyl-CoA:cholesterol acyltransferase inhibitor composition which contains an effective amount of a heterocyclic compound of the general formula: ##STR30## wherein ring A and ring B each means a benzene ring which is unsubstituted or substituted by 1 to 4 substituents selected from a group consisting of a halogen, C.sub.1-6 alkyl optionally halogenated, C.sub.1-6 alkoxy optionally halogenated, C.sub.1-6 alkylthio optionally halogenated, C.sub.1-3 acyloxy, di-C.sub.1-6 alkylamino and hydroxy, X means a group of the formula: ##STR31## wherein R.sup.2 is hydrogen, an alkyl or an alkoxy; m is 0 or 1, or the formula: ##STR32## wherein R.sup.3 is hydrogen or an alkyl; Y means a bond, --NH--, an C.sub.1 or 2 alkylene or --CH=CH--; R.sup.1 is a C.sub.1-8 alkyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkyl-C.sub.1-4 alkyl, C.sub.6-10 aryl or C.sub.7-16 aralkyl group which may be substituted by 1 to 5 substituents selected from a group consisting of a halogen, C.sub.1-6 alkyl optionally halogenated, C.sub.1-6 alkoxy optionally halogenated, C.sub.1-6 alkylthio optionally halogenated, C.sub.1-3 acyloxy, di-C.sub.1-6 alkylamino and hydroxy; and n means a whole number of 3 through 6, or a pharmaceutically acceptable salt thereof, optionally together with a pharmaceutically acceptable carrier.
- 8. A method for inhibiting acyl-CoA:cholesterol acyltransferase which comprises administrating an effective amount of a compound as claimed in claim 1 optionally together with a pharmaceutically acceptable carrier to a mammal requiring such inhibition.
Priority Claims (2)
Number |
Date |
Country |
Kind |
2-259657 |
Sep 1990 |
JPX |
|
3-202003 |
Aug 1991 |
JPX |
|
Parent Case Info
This application is a divisional of Ser. No. 07/765,182, filed Sep. 25, 1991, now U.S. Pat. No. 5,264,454.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3798226 |
Meguro et al. |
Mar 1974 |
|
3862152 |
Kuwada et al. |
Jan 1975 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
0354994 |
Feb 1990 |
EPX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
765182 |
Sep 1991 |
|